|Page (1) of 1 - 07/26/12||email article||print page|
Swiss drugmaker Roche posts 7 percent profit rise, helped by sale of cancer drugs
GENEVA (AP) ¯¯¯ Swiss drug maker Roche Holding AG has reported a 7 percent rise in core operating profit to 8.6 billion Swiss francs in the first half, helped by sales of cancer drugs and recent cost-cutting.
The Basel, Switzerland-based company's half-year results also show that excluding the effect of the strong Swiss currency its group sales rose 4 percent to 22.4 billion francs.
The company's results issued Thursday before the opening of the Zurich exchange said that its net income fell 14 percent mainly due to one-off costs from the closure of its Nutley, New Jersey, site.
The former U.S. headquarters is to be closed by the end of 2013 in a money-saving consolidation of research and development programs.
Roche also confirmed its full-year outlook for sales in low to middle single-digit rates.